You are here
- Home
- Drug Products
- All Drug Products
A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa
- Disease
- lung cancer
- Drug Name
- IRESSA
- Generic Name
- gefitinib
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- IV
- Start Date
- Aug 1, 2009
- Study Name
- 1839IL/0052 SubStudy
- Study Id
- 1839IL/0052 SubStudy
- ClinicalTrials.gov ID
- NCT01000740
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report
-
Aug 31, 2010
- 1839IL/0052.pdf (121 KB)
